Product Information
AMLODIPINE-ATORVAST 5-10 MG is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.0487 per EA under NDC 00378451393. Its NADAC has been published 585 times since Jun 10, 2015.
FDA first approved this application on Nov 29, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 10 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378451393
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA200465FDA Approved
11/29/2013
TE Code
AB
On Market Since
4/2/2015
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-ATORVAST 5-10 MG has been published 585 times since Jun 10, 2015, and over the history we have for it it has declined 74.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0487 per EA |
|---|---|
| All-time high | $4.7188 (Nov 11, 2015) |
| All-time low | $0.7019 (Jul 17, 2024) |
| 52-week high | $1.3847 |
| 52-week low | $1.0211 |
| Median price | $2.4914 |
| Average price | $2.4167 |
| Largest weekly change | +78.9% (Oct 19, 2022) |
| Weeks tracked | 585 |
| Tracking since | Jun 10, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Amlodipine and atorvastatin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-ATORVAST 5-10 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 5-10 MG, manufactured by Mylan Pharmaceuticals Inc., is $1.0487 per EA (NDC 00378451393), effective Aug 19, 2026.
How has the price of AMLODIPINE-ATORVAST 5-10 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 5-10 MG has declined 74.4%. It has been tracked across 585 weekly CMS publications since Jun 10, 2015.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 5-10 MG?
Since Jun 10, 2015, the NADAC for AMLODIPINE-ATORVAST 5-10 MG has ranged from a low of $0.7019 (Jul 17, 2024) to a high of $4.7188 (Nov 11, 2015), with a median of $2.4914 per EA.
Are there cheaper alternatives to AMLODIPINE-ATORVAST 5-10 MG?
No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-ATORVAST 5-10 MG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AMLODIPINE-ATORVAST 5-10 MG?
AMLODIPINE-ATORVAST 5-10 MG (NDC 00378451393) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.